All articles by Archana Rani

CTI announces partnership for oncology drug development

CTI Clinical Trial & Consulting Services (CTI) and Crown Bioscience have announced a strategic partnership aimed at bolstering consulting services…
Touchlight to supply GMP dbDNA for UK Zika vaccine study

Contract development and manufacturing organisation Touchlight has collaborated with the UK's University of Nottingham to supply good manufacturing practice (GMP)…
Innovent’s Dupert approved in China to treat lung cancer

China's National Medical Products Administration (NMPA) has granted approval for Innovent Biologics’ Kristen rat sarcoma (KRAS) G12C inhibitor, Dupert (fulzerasib),…
FDA accepts BMS’ sBLA for Opdivo-Yervoy combo for HCC

The US Food and Drug Administration (FDA) has accepted the supplemental biologics licence application (sBLA) filed by Bristol Myers Squibb…
Accenture invests in Earli to advance early cancer detection tech

Accenture has invested in biotechnology company Earli to advance early cancer detection technologies. Facilitated through Accenture Ventures, the investment aims…

Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval

Biopharmaceutical company Liquidia has received tentative approval from the US Food and Drug Administration (FDA) for YUTREPIA (treprostinil) inhalation powder…
NMPA approves Astellas’ PADCEV for advanced urothelial cancer

The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved Astellas’ PADCEV (enfortumab vedotin), a…
EC approves AbbVie’s TEPKINLY for follicular lymphoma

The European Commission (EC) has granted conditional marketing authorisation for AbbVie’s TEPKINLY (epcoritamab), an IgG1-bispecific antibody, for the treatment of…
Gilead Sciences reports net income rise in Q2 2024

Gilead Sciences has reported net income attributable to the company at $1.61bn, up from $1.04bn in the corresponding quarter of…
WuXi Biologics and Medigene link on T cell engagers for cancer

Global contract research, development and manufacturing organisation (CRDMO) WuXi Biologics has partnered with Medigene to develop TCR-guided T cell engagers…